Browse the evidence

Combining aerobic exercise with fasting protocols produces greater weight loss, fat reduction, and metabolic improvements in obese women than either intervention alone.

For obese women seeking effective weight loss, combining regular aerobic exercise (like walking, cycling, or swimming) with a fasting protocol (such as intermittent fasting or time-restricted feeding) is more effective than doing either alone. This approach leads to greater fat loss, improved insulin sensitivity, and better lipid profiles. Start with a manageable fasting window and a consistent exercise routine, and monitor your progress. This strategy is supported by robust mechanistic insights and practical benefits, making it a valuable addition to comprehensive obesity management programs.

A structured 12-week calorie-restricted dietary intervention starting with a 6-week Very Low-Calorie Diet (VLCD) phase (800-1200 kcal/day) followed by a 6-week maintenance phase significantly reduces body weight and improves postprandial glycemic response in Korean adults with early type 2 diabetes and obesity.

For Korean adults with early type 2 diabetes and obesity, a structured 12-week program starting with a 6-week very low-calorie diet (800-1200 kcal/day, with meals provided) followed by a 6-week self-managed maintenance phase can lead to significant weight loss (approx. 7-8%) and improved blood sugar control. The key is the structured, phased approach and meal provision to ensure adherence.

Short-term provision of Healthy Ketogenic Diet Ready-To-Eat (HKD-RTE) meals enhances initial weight loss and adherence compared to HKD counseling alone, leading to sustained greater weight reduction at 6 months despite the RTE intervention ending after one month.

If you struggle with the time and effort of preparing a ketogenic diet, try using ready-to-eat meals that fit your macros for the first month. This study suggests that this short-term convenience can help you establish better habits and lose more weight in the long run (6 months) compared to just getting advice. Focus on getting the first month right with convenient, pre-made meals to build momentum.

Adherence to Healthy Ketogenic Diet Ready-To-Eat (HKD-RTE) meals is positively associated with greater weight loss, with each 1% increase in compliance linked to additional weight loss over 3 months.

Your weight loss is directly tied to how consistently you follow the meal plan. Even small improvements in your compliance (like eating your pre-made meals more often) can lead to extra weight loss. Don't aim for perfection; aim for consistency, as every bit of compliance counts.

Nutritional guidance that dynamically adjusts energy intake based on regular measurements of Resting Energy Expenditure (REE) and physical activity effectively reduces body weight in patients with obesity without triggering metabolic adaptation (REE reduction) or increasing hunger.

To lose weight without triggering your body's survival mechanisms (slowed metabolism and intense hunger), you must tailor your calorie intake to your specific energy burn. This involves measuring your Resting Energy Expenditure (REE) and tracking physical activity, then adjusting your daily calorie target regularly (e.g., weekly) as your body changes. Use technology like meal-tracking apps to ensure you are hitting these dynamic targets. This personalized approach allows for significant weight loss (approx. 5% in 24 weeks) while keeping your metabolism and hunger levels stable.

Combining High-Intensity Interval Training (HIIT) with Resistance Training (RT) increases lean muscle mass and reduces visceral fat more effectively than Moderate-Intensity Continuous Training (MICT) alone in postmenopausal women.

If you are a postmenopausal woman looking to lose visceral fat and build muscle, combine short, intense cardio intervals with resistance training 3 times a week instead of just doing steady-state cardio.

Both 5:2 and 16:8 intermittent fasting protocols produce statistically significant weight loss in overweight and obese individuals over a 6-week period, with no statistically significant difference in efficacy between the two methods.

If you are overweight or obese, you can choose either the 5:2 method (eating very little on 2 days a week) or the 16:8 method (eating within an 8-hour window daily) to lose weight. Both work significantly over 6 weeks, and neither is proven to be better than the other. Pick the one you can stick with consistently.

Structured calorie-restricted diets (800-1,800 kcal) can induce diabetes remission in obese Korean adults with early-onset Type 2 Diabetes, with remission rates up to 75%.

If you have recently been diagnosed with Type 2 Diabetes and are obese, a structured diet starting at 800 calories and moving to 1,200-1,800 calories can potentially put your diabetes into remission, especially if you stop other medications under doctor supervision.

A 12-month digital weight management program integrating tirzepatide with behavioral coaching achieves clinically meaningful weight loss (mean 22.7%) and significant improvements in binge eating and depressive symptoms.

If you have obesity and are considering medication, a structured program that combines tirzepatide with digital coaching and support can lead to significant weight loss (over 22% on average) and improvements in mental health and binge eating. Expect some initial side effects like nausea, but these often subside, and clinical support is available to help you manage them.

Both volumetric dieting (energy density ≤ 1.5 kcal/g) and time-restricted eating (8-hour window) produce equivalent reductions in body weight and fat mass while preserving lean body mass in middle-aged, physically active adults over 12 weeks.

If you want to lose fat and keep muscle without changing your exercise routine, you can choose either to eat lower-energy-density foods (more volume, fewer calories per gram) or to eat all your calories within an 8-hour window. Both methods worked equally well in this study. Choose the one you can stick to consistently, as adherence was higher for the time-restricted eating group.

Combining 16:8 TRE with exercise significantly reduces triglycerides and LDL cholesterol compared to exercise alone, with greater LDL-C reductions observed in men.

If you exercise regularly, adding a 16:8 time-restricted eating schedule may lead to small but significant improvements in triglycerides and LDL cholesterol (bad cholesterol) compared to exercising without dietary timing restrictions. Men may see greater improvements in LDL-C. These benefits are modest and should be viewed as part of a broader cardiometabolic risk-reduction plan.

A structured very-low-calorie ketogenic diet (VLCKD) administered for 17-19 weeks effectively reverses insufficient weight loss and weight regain in post-bariatric surgery patients, achieving significant fat mass reduction while preserving muscular strength and metabolic health.

If you have had bariatric surgery but haven't lost enough weight or have regained it, a structured Very-Low-Calorie Ketogenic Diet (VLCKD) is a viable, safe, and effective option. The protocol involves a strict 6-week active phase (approx. 600 kcal, very low carb, high protein), followed by a gradual re-introduction of foods over 13 more weeks. Crucially, you must continue your prescribed post-surgical vitamin and mineral supplements to avoid deficiencies. This approach can help you lose significant fat while keeping your muscle strength, without harming your liver or kidneys, provided you are not diabetic or have other severe comorbidities.

Wearable activity trackers lead to improvements in body composition, specifically bodyweight and waist circumference, with large effect sizes for bodyweight reduction.

Using a wearable activity tracker can help you lose weight, with an average reduction of 0.5 to 1.5 kg. This benefit is seen in both healthy adults and those with chronic conditions like diabetes or heart disease. The weight loss is a result of the increased physical activity driven by the tracker.

Resistance exercise prescribed at two sessions per week with high effort (RPE 3-5 progressing to 6-8 or 40-85% 1RM) is the recommended first-line treatment for sarcopenia in older adults.

Perform resistance exercises twice a week, covering both upper and lower body. Start with 1-3 sets of 6-12 reps per exercise. Use a weight or resistance that feels like 'somewhat hard' to 'hard' effort (RPE 3-5 initially, aiming for 6-8). Focus on correct form before adding weight. If you are very weak, start with just one session a week or use bodyweight only, then build up. Ensure at least 48 hours rest between sessions. Continue for at least 12 weeks to see benefits.

Management of sarcopenic obesity requires a combined approach of resistance and aerobic exercise with moderate caloric restriction and high-quality protein intake, as caloric restriction alone can exacerbate muscle loss.

Do not just diet. Combine moderate calorie cutting with high-protein eating (1-1.2g/kg/day) and a mix of resistance and aerobic exercise. This protects your muscles while losing fat. Avoid extreme low-calorie diets which can harm your muscle mass.

Sprint Interval Training (SIT), a variant of HIIT involving near-maximal to 'all out' efforts, can improve endurance performance in highly trained athletes by enhancing fatigue resistance and durability.

For elite endurance athletes, adding short, maximal-effort sprints (SIT) to your regular training can improve your ability to sustain performance when fatigued. This is an advanced technique; ensure it is periodized correctly within your overall training plan to avoid overtraining. It is not for beginners.

Lifestyle interventions, specifically the Mediterranean diet combined with physical activity, are the primary therapeutic strategy for preventing and treating metabolic syndrome by addressing modifiable risk factors such as obesity and insulin resistance.

Adopt a Mediterranean-style diet focusing on whole foods, healthy fats, and limited processed sugars and salts. Combine this with at least 30 minutes of daily physical activity. This is the foundational treatment for Metabolic Syndrome, often more effective than medication alone for long-term management.

Chatbot interventions significantly increase total physical activity, daily steps, and moderate-to-vigorous physical activity (MVPA) compared to control conditions.

Use a chatbot app or platform that sends daily prompts or allows you to log your activity and diet. Look for tools that use goal-setting and feedback features. Consistency is key, even if the interaction is brief. This is a low-cost, accessible way to boost your daily movement and healthy eating habits.

Chatbot interventions significantly increase fruit and vegetable consumption, with text-based and AI/NLP-enabled chatbots being more effective than voice-based or non-AI chatbots.

Choose a chatbot that uses text or AI features for dietary tracking. Use it when you are shopping or preparing food to log your intake. This method is more effective for improving fruit and vegetable consumption than voice-only options.

Adopting a Mediterranean diet and maintaining adequate protein intake (1.1–1.2 g/kg/day) are essential public health strategies to prevent chronic diseases, sarcopenia, and functional decline in older adults.

To age healthily, prioritize a Mediterranean-style diet rich in plants, fish, and olive oil, and ensure you are eating enough protein—specifically 1.1 to 1.2 grams per kilogram of your body weight daily. This higher protein target is crucial for preventing muscle loss (sarcopenia) and maintaining your ability to live independently. Combine this with regular physical activity, including resistance and balance exercises, to support your physical and cognitive health.

Regular physical activity, including resistance, aerobic, and balance exercises, reduces the risk of chronic diseases, cognitive decline, and functional impairment in older adults.

Engage in regular physical activity tailored to your abilities. Include resistance training to build muscle, aerobic exercise for heart health, and balance activities to prevent falls. Even moderate activity like walking can significantly reduce the risk of dementia and chronic diseases, improving your quality of life.

Younger individuals (≤50 years) experience more significant weight and waist circumference reductions from Survodutide compared to older individuals (>50 years).

If you are 50 years or younger, you may experience greater weight loss from Survodutide than those over 50. This is likely due to metabolic differences and fewer comorbidities in younger patients, but the drug remains effective across age groups.

Expanding access to GLP-1 and GIP/GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) for eligible populations in the US could avert approximately 43,719 deaths annually by reducing obesity-related mortality.

If you have a BMI of 30 or higher (or 27+ with conditions like diabetes), you are likely eligible for GLP-1 medications like semaglutide or tirzepatide. These drugs are highly effective for weight loss and can significantly reduce your risk of early death from obesity-related causes. The main barrier is not efficacy, but cost and insurance coverage. Discuss these options with your doctor and explore insurance coverage options or patient assistance programs, as expanded access policies may soon make these treatments more available and affordable.

Tirzepatide is the only obesity management medication shown to significantly reduce the Apnea-Hypopnea Index (AHI) and achieve remission of Obstructive Sleep Apnea Syndrome (OSAS) in patients with obesity.

If you have obesity and sleep apnea, Tirzepatide has been shown to significantly reduce the severity of your sleep apnea (AHI) and can lead to remission of the condition. This is a unique benefit not clearly demonstrated by other weight loss drugs in this review.